Skip to Content

REKAMBYS 600 mg prolonged-release suspension for injection

Licence status
Authorised: 17/12/2020
Active substances
Rilpivirine
Dosage Form
Prolonged-release suspension for injection
Licence number
EU/1/20/1482/001
Licence holder
Janssen-Cilag International NV

Licence information

ATC code
J05AG05 rilpivirine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
17/12/2020